Pharmaceutical Industry Information Portal

HomeNewsletter

Newsletter

Valneva shares drop 20% after deal with EU on COVID vaccine is broken

Shares of Valneva plunged 20% on Monday after the French drugmaker said its COVID-19 vaccine agreement with the European Commission was being scrapped and...

Inventiva raises €50 million credit line from the European Investment Bank

Inventiva, a clinical-stage biopharmaceutical company focused on the development of oral small molecule therapies for the treatment of patients with non-alcoholic steatohepatitis (NASH) and...

Abbott caused the baby formula crisis, but who will be held responsible

U.S. Secretary of Transportation Pete Buttigieg on Sunday blamed the worsening baby formula shortage on Abbott Nutrition, one of the largest formula suppliers in...

Investment in healthcare in Saudi Arabia drives transformation

Global healthcare is currently experiencing a substantial shift in the way it operates and caters to patient needs, driven by advancements in science and...

Veru shares up 38.5% YTD, but Q2 loss missed earnings expectations

Veru Inc. came out with a quarterly loss of $0.18 per share versus the Zacks Consensus Estimate of a loss of $0.16. This compares...

Sun Pharma shares up 4% after FDA approves mesalamine capsules

Sun Pharmaceutical Industries Limited, announced that it has received final approval from US FDA for its Abbreviated New Drug Application (ANDA) for generic Mesalamine...
spot_img

Expert Articles

spot_img